NCT01592552View on ClinicalTrials.gov

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Alzheimer's DiseaseMultiple SclerosisParkinson's DiseaseHuntington's DiseaseAmyotrophic Lateral Sclerosis (ALS)
Trial Locations (1)

91403

Sanguine Biosciences, Sherman Oaks

Sponsors
All Listed Sponsors
lead

Sanguine Biosciences

INDUSTRY

NCT01592552 - A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery | Biotech Hunter | Biotech Hunter